Promakhos Therapeutics

Promakhos Therapeutics YC 申请

Summer 2021Active

Promakhos Therapeutics 在 Summer 2021 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是:公司做什么、谁创立了它,以及其 YC 申请,按照真实 YC 表格逐题重建。

YC 批次
Summer 2021
行业
HealthcareTherapeutics
团队规模
2
状态
Active
已发布
2021

创始人

  • Katerina Chatzi
    Katerina ChatziFounder
  • Jasper Edgar Neggers
    Jasper Edgar NeggersFounder

Promakhos Therapeutics 做什么

We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.

Promakhos Therapeutics 的 YC 申请,重建版

Y Combinator 申请

Promakhos Therapeutics,Summer 2021 期。来自公开数据的真实申请问题解答。

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Promakhos Therapeutics

Describe what your company does in 50 characters or less.

A therapeutics platform for curing inflammatory disorders

What is your company going to make? Please describe your product and what it does or will do.

We are building a platform that uses bacterial molecules to trigger the body's innate ability to regulate inflammation and heal itself. Our first target is Crohn's Disease, with plans to expand to type 1 Diabetes and Multiple Sclerosis. The product is a new kind of therapy designed to control inflammation from within.

Where do you live now, and where would the company be based after YC?

We live in Boston, MA and the company will remain based here after YC.

Explain your decision regarding location.

Boston is a hub for biotech and therapeutics research with access to top expertise and infrastructure, which is essential for us given the scientific complexity of our platform.

21 更多回答 在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开,紧邻每个其他 YC 批次。

常见问题解答

这是 Promakhos Therapeutics 的真实 YC 申请吗?

不是。Y Combinator 对提交的申请保密。这是重建版:使用 Promakhos Therapeutics 的公开数据(发布笔记、创始人背景、产品描述)回答真实的 YC 表格问题。它展示了像 Promakhos Therapeutics 这样的公司会如何向 YC 自我介绍,而不是他们提交的文本。

Promakhos Therapeutics 是哪个 YC 批次的?

Promakhos Therapeutics 是 Y Combinator Summer 2021 批次的成员。

谁创立了 Promakhos Therapeutics?

Promakhos Therapeutics 由 Katerina Chatzi, Jasper Edgar Neggers 创立。

Promakhos Therapeutics 做什么?

A therapeutics platform for curing inflammatory disorders

如何阅读完整的重建申请?

创建免费的 Round Funded 账户。YC Insights 中包含 Promakhos Therapeutics 的完整 26 个问题的版本,以及其他所有 YC 批次的公司信息。

更多 YC 初创公司,例如 Promakhos Therapeutics